• Equivac TAT is used in the treatment and prevention of tetanus due to Clostridium tetani.
• Equivac TAT is one of a range of Equivac products available for tetanus treatment and control.
• Equivac TAT is not a vaccine. It is a purified concentrated hyperimmune antiserum containing antibodies to tetanus toxin.
• Equivac TAT is approved for use in horses, cattle, sheep, goats, pigs and dogs.

• Equivac TAT provides a means of immediate protection against tetanus where the animal is not vaccinated.
• Combined Active-Passive Protection: Equivac T or Equivac® 2in1 can be administered simultaneously with Equivac TAT. A separate needle and syringe should be used for each product and administration should be on opposite sides of the body. If initiating a primary course the second dose of Equivac T or Equivac 2in1 should be administered 4 to 6 weeks later.

• Prevention of tetanus:
• Horses and foals and adult cattle: not less than 1 mL (1500 iu) injected subcutaneously (s/c). Calves, sheep, goats and pigs: not less than 500 iu s/c.
• Dogs: not less than 250 iu s/c.
• Lambs and piglets: not less than 100 iu s/c.
• Treatment of clinically diagnosed tetanus: 10000-20000 u injected slowly intravenously. Antitoxin as a treatment is less successful than as a prevention. Equivac TAT as a treatment is best given early in the disease.

• Withholding periods for food producing species: zero (0) days.
• For horses, Equivac TAT should remain at a preventative level in the plasma for 2-3 weeks.

Storage:

Store between 2°C and 8°C. (Refrigerate. Do not freeze). Protect from light.